Annovis reports similar pharmacokinetics for new crystal buntanetap

Annovis Bio, Inc. has published results in Biomolecules showing that its newly developed dihydrate crystal form of buntanetap, which contains two moles of water, retains essentially the same pharmacokinetic (absorption, clearance, metabolism) profile as its original anhydrous form in studies involving mice, dogs, and humans. The company said that the original form has been used […] The post Annovis reports similar pharmacokinetics for new crystal buntanetap appeared first on Longevity.Technology.